论文部分内容阅读
目的评价倍他洛克(Be-taloc)在临床上应用的情况。方法收集武汉亚洲心脏病医院2004年门诊处方37293张,其中使用倍他洛克的处方数为7237张,并对处方进行分类统计分析。结果使用倍他洛克的处方占处方总数的19.4%;倍他洛克单独使用的处方占10.1%;联合用药的处方占89.9%,其中与抗高血压、抗心绞痛、抗心律失常药物和其它药物合用处方分别占40.7%、28.2%、17.6%、13.5%。结论倍他洛克已广泛用于心血管疾病的治疗,其主要使用方法是联合用药。
Objective To evaluate the clinical application of Be-taloc. Methods A total of 37 293 outpatient prescriptions were collected from Wuhan Asian Cardiology Hospital in 2004, of which 7237 prescriptions were used, and the prescriptions were classified and analyzed statistically. Results The use of betaxolol accounted for 19.4% of the total number of prescriptions; betaxolol used only 10.1% of the prescriptions; and the combination prescriptions accounted for 89.9% of the total, with antihypertensive, antianginal, antiarrhythmic and other drugs Prescriptions accounted for 40.7%, 28.2%, 17.6% and 13.5% respectively. Conclusion Betaloc has been widely used in the treatment of cardiovascular diseases, and its main method of use is combination therapy.